Zosano Announces FDA Submission of New Drug Application for Qtrypta
December 23, 2019 08:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the submission of a 505(b)(2) New Drug...
Zosano Announces Pricing of Registered Direct Offering
November 27, 2019 09:29 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase...
Zosano Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 14, 2019 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended...
Zosano Pharma Announces Completion of Pre-NDA Meetings with FDA for Qtrypta™
November 13, 2019 16:30 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has received minutes from pre- New...
Zosano Pharma to Host Conference Call on Third Quarter 2019 Financial Results and Provide Operational Update
November 07, 2019 09:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and...
Zosano Pharma Initiates Phase 2/3 Clinical Study in Cluster Headache
October 24, 2019 09:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has begun enrolling cluster...
Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 23, 2019 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock...
Zosano Pharma Announces CEO Transition
October 08, 2019 09:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that Steven Lo, veteran biotechnology and...
Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 27, 2019 16:05 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock...
Zosano Pharma to Present at the Cantor Global Healthcare Conference
September 26, 2019 09:00 ET
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief...